Meditation and vacation effects have an impact on disease-associated molecular phenotypes

Translational Psychiatry

Volumn 6, Issue 8, 2016, Pages

  Epel, E S ^a   Puterman, E ^a   Lin, J ^b   Blackburn, E H ^b   Lum, P Y ^c   Beckmann, N D ^d   Zhu, J ^d   Lee, E ^d   Gilbert, A ^a   Rissman, R A ^e   Tanzi, R E ^f   Schadt, E E ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Capella Biosciences   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA-PROTEIN (1-42); PEPTIDE FRAGMENT; TUMOR NECROSIS FACTOR;

ADULT; AGING; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; HUMAN; IMMUNITY; IMMUNOLOGY; LEISURE; MEDITATION; MENTAL HEALTH; MENTAL STRESS; METABOLISM; MIDDLE AGED; PHENOTYPE; PHYSIOLOGICAL STRESS; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; THERAPY;

ADULT; AGING; AMYLOID BETA-PEPTIDES; FEMALE; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; HOLIDAYS; HUMANS; IMMUNITY; MEDITATION; MENTAL HEALTH; MIDDLE AGED; PEPTIDE FRAGMENTS; PHENOTYPE; STRESS, PHYSIOLOGICAL; STRESS, PSYCHOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85014593814     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/TP.2016.164     Document Type: Article

References (50)

1. Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A 2014; 69(Suppl 1): S4–S9.
2. McEwen BS. Protective and damaging effects of stress mediators. N Engl J Med 1998; 338: 171–179.
3. Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med 1999; 340: 115–126.
4. Ferreira ST, Clarke JR, Bomfim TR, De Felice FG. Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease. Alzheim Dementia 2014; 10(1 Suppl): S76–S83.
5. Machado A, Herrera AJ, de Pablos RM, Espinosa-Oliva AM, Sarmiento M, Ayala A et al. Chronic stress as a risk factor for Alzheimer's disease. Rev Neurosci 2014; 25: 785–804.
6. Zhang B, Gaiteri C, Bodea LG, Wang Z, McElwee J, Podtelezhnikov AA et al. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease. Cell 2013; 153: 707–720.
7. Kidd BA, Peters LA, Schadt EE, Dudley JT. Unifying immunology with informatics and multiscale biology. Nat Immunol 2014; 15: 118–127.
8. Rode L, Nordestgaard BG, Bojesen SE. Peripheral blood leukocyte telomere length and mortality among 64,637 individuals from the general population. J Natl Cancer Inst 2015; 107: djv074.
9. D'Mello MJ, Ross SA, Briel M, Anand SS, Gerstein H, Pare G. Association between shortened leukocyte telomere length and cardiometabolic outcomes: systematic review and meta-analysis. Circ Cardiovasc Genet 2015; 8: 82–90.
10. Damjanovic AK, Yang Y, Glaser R, Kiecolt-Glaser JK, Nguyen H, Laskowski B et al. Accelerated telomere erosion is associated with a declining immune function of caregivers of Alzheimer's disease patients. J Immunol 2007; 179: 4249–4254.
11. Epel ES, Blackburn EH, Lin J, Dhabhar FS, Adler NE, Morrow JD et al. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci USA 2004; 101: 17312–17315.
12. Rothman SM, Herdener N, Camandola S, Texel SJ, Mughal MR, Cong WN et al. 3xTgAD mice exhibit altered behavior and elevated Abeta after chronic mild social stress. Neurobiol Aging 2012; 33: 830 e1–12.
13. Chouraki V, Beiser A, Younkin L, Preis SR, Weinstein G, Hansson O et al. Plasma amyloid-beta and risk of Alzheimer's disease in the Framingham Heart Study. Alzheim Dementia 2015; 11: 249–57 e1.
14. Chiesa A, Serretti A. Mindfulness-based stress reduction for stress management in healthy people: a review and meta-analysis. J Altern Complement Med 2009; 15: 593–600.
15. Dharmawardene M, Givens J, Wachholtz A, Makowski S, Tjia J. A systematic review and meta-analysis of meditative interventions for informal caregivers and health professionals. Br Med J 2015; 6: 160–169.
16. Goyal M, Singh S, Sibinga EM, Gould NF, Rowland-Seymour A, Sharma R et al. Meditation programs for psychological stress and well-being: a systematic review and meta-analysis. JAMA Intern Med 2014; 174: 357–368.
17. Jacobs TL, Epel ES, Lin J, Blackburn EH, Wolkowitz OM, Bridwell DA et al. Intensive meditation training, immune cell telomerase activity, and psychological media-tors. Psychoneuroendocrinology 2011; 36: 664–681.
18. Schutte NS, Malouff JM. A meta-analytic review of the effects of mindfulness meditation on telomerase activity. Psychoneuroendocrinology 2014; 42: 45–48.
19. Carlson LE, Beattie TL, Giese-Davis J, Faris P, Tamagawa R, Fick LJ et al. Mindfulness-based cancer recovery and supportive-expressive therapy maintain telomere length relative to controls in distressed breast cancer survivors. Cancer 2015; 121: 476–484.
20. Lengacher CA, Reich RR, Kip KE, Barta M, Ramesar S, Paterson CL et al. Influence of mindfulness-based stress reduction (MBSR) on telomerase activity in women with breast cancer (BC). Biol Res Nursing 2014; 16: 438–447.
21. Lavretsky H, Epel ES, Siddarth P, Nazarian N, Cyr NS, Khalsa DS et al. A pilot study of yogic meditation for family dementia caregivers with depressive symptoms: effects on mental health, cognition, and telomerase activity. Int J Geriatr Psychiatry 2012; 28: 57–65.
22. Creswell JD, Irwin MR, Burklund LJ, Lieberman MD, Arevalo JM, Ma J et al. Mindfulness-based stress reduction training reduces loneliness and pro-inflammatory gene expression in older adults: a small randomized controlled trial. Brain Behav Immun 2012; 26: 1095–1101.
23. Black DS, Slavich GM. Mindfulness meditation and the immune system: a systematic review of randomized controlled trials. Ann N Y Acad Sci 2016; 1373: 13–24.
24. Bower JE, Irwin MR. Mind-body therapies and control of inflammatory biology: a descriptive review. Brain Behav Immunn 2016; 51: 1–11.
25. Bhasin MK, Dusek JA, Chang BH, Joseph MG, Denninger JW, Fricchione GL et al. Relaxation response induces temporal transcriptome changes in energy metabolism, insulin secretion and inflammatory pathways. PLoS ONE 2013; 8: e62817.
26. Kaliman P, Alvarez-Lopez MJ, Cosin-Tomas M, Rosenkranz MA, Lutz A, Davidson RJ. Rapid changes in histone deacetylases and inflammatory gene expression in expert meditators. Psychoneuroendocrinology 2014; 40: 96–107.
27. Qu S, Olafsrud SM, Meza-Zepeda LA, Saatcioglu F. Rapid gene expression changes in peripheral blood lymphocytes upon practice of a comprehensive yoga pro-gram. PLoS ONE 2013; 8: e61910.
28. Fox KC, Nijeboer S, Dixon ML, Floman JL, Ellamil M, Rumak SP et al. Is meditation associated with altered brain structure? A systematic review and meta-analysis of morphometric neuroimaging in meditation practitioners. Neurosci Biobehav Rev 2014; 43: 48–73.
29. Supek F, Bosnjak M, Skunca N, Smuc T. REVIGO summarizes and visualizes long lists of gene ontology terms. PLoS ONE 2011; 6: e21800.
30. Millstein J, Zhang B, Zhu J, Schadt EE. Disentangling molecular relationships with a causal inference test. BMC Genet 2009; 10: 23.
31. Schadt EE, Lamb J, Yang X, Zhu J, Edwards S, Guhathakurta D et al. An integrative genomics approach to infer causal associations between gene expression and disease. Nat Genet 2005; 37: 710–717.
32. Zhu J, Sova P, Xu Q, Dombek KM, Xu EY, Vu H et al. Stitching together multiple data dimensions reveals interacting metabolomic and transcriptomic networks that modulate cell regulation. PLoS Biol 2012; 10: e1001301.
33. Zhu J, Zhang B, Smith EN, Drees B, Brem RB, Kruglyak L et al. Integrating large-scale functional genomic data to dissect the complexity of yeast regulatory networks. Nat Genet 2008; 40: 854–861.
34. Sweet T, Khalili K, Sawaya BE, Amini S. Identification of a novel protein from glial cells based on its ability to interact with NF-kappaB subunits. J Cell Biochem 2003; 90: 884–891.
35. Sweet T, Yen W, Khalili K, Amini S. Evidence for involvement of NFBP in processing of ribosomal RNA. J Cell Physiol 2008; 214: 381–388.
36. Huang P, Zhou ZR, Zheng MQ, Shi FX. Effect of the IGF-1/PTEN/Akt/FoxO signaling pathway in the duodenal mucosa of rats subjected to water immersion and restraint stress. Genet Mol Res 2012; 11: 4775–4788.
37. Zhou W, Chen L, Yang S, Li F, Li X. Behavioral stress-induced activation of FoxO3a in the cerebral cortex of mice. Biol Psychiatry 2012; 71: 583–592.
38. Lutzner N, Kalbacher H, Krones-Herzig A, Rosl F. FOXO3 is a glucocorticoid receptor target and regulates LKB1 and its own expression based on cellular AMP levels via a positive autoregulatory loop. PLoS ONE 2012; 7: e42166.
39. Zhu Q, Jin L, Casero RA, Davidson NE, Huang Y. Role of ornithine decarboxylase in regulation of estrogen receptor alpha expression and growth in human breast cancer cells. Breast Cancer Res Treat 2012; 136: 57–66.
40. Lavretsky H, Epel ES, Siddarth P, Nazarian N, Cyr NS, Khalsa DS et al. A pilot study of yogic meditation for family dementia caregivers with depressive symptoms: effects on mental health, cognition, and telomerase activity. Int J Geriatr Psychiatry 2013; 28: 57–65.
41. Zhao J, Miao K, Wang H, Ding H, Wang DW. Association between telomere length and type 2 diabetes mellitus: a meta-analysis. PLoS ONE 2013; 8: e79993.
42. Wentzensen IM, Mirabello L, Pfeiffer RM, Savage SA. The association of telomere length and cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2011; 20: 1238–1250.
43. Ornish D, Lin J, Daubenmier J, Weidner G, Epel E, Kemp C et al. Increased telo-merase activity and comprehensive lifestyle changes: a pilot study. Lancet Oncol 2008; 9: 1048–1057.
44. Ornish D, Lin J, Chan JM, Epel E, Kemp C, Weidner G et al. Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study. Lancet Oncol 2013; 14: 1112–1120.
45. Baskaran A, Carvalho AF, Mansur RB, McIntyre RS. Are major depressive disorder and diabetes mellitus amyloidogenic conditions? CNS Neurol Disord Drug Targets 2014; 13: 1667–1676.
46. Harrington KD, Lim YY, Gould E, Maruff P. Amyloid-beta and depression in healthy older adults: a systematic review. Aust N Z J Psychiatry 2015; 49: 36–46.
47. Koyama A, Okereke OI, Yang T, Blacker D, Selkoe DJ, Grodstein F. Plasma amyloid-beta as a predictor of dementia and cognitive decline: a systematic review and meta-analysis. Arch Neurol 2012; 69: 824–831.
48. Gabelle A, Schraen S, Gutierrez LA, Pays C, Rouaud O, Buee L et al. Plasma beta-amyloid 40 levels are positively associated with mortality risks in the elderly. Alzheim Dementia 2014; 11: 672–680.
49. Bertram L, Tanzi RE. Alzheimer disease: new light on an old CLU. Nat Rev Neurol 2010; 6: 11–13.
50. Armanios M, Blackburn EH. The telomere syndromes. Nat Rev Genet 2012; 13: 693–704.